270
Participants
Start Date
April 30, 2016
Primary Completion Date
August 31, 2017
Study Completion Date
December 31, 2017
GNbAC1
Monthly IV repeated dose
Placebo
Monthly IV repeated dose
Sofia
Zagreb
Jihlava
Tallinn
Berlin
Budapest
Roma
Warsaw
Moscow
Belgrade
Barcelona
Kharkiv
Lead Sponsor
Collaborators (1)
Les Laboratoires Servier (LLS)
UNKNOWN
Institut de Recherches Internationales Servier
OTHER
Worldwide Clinical Trials
OTHER
GeNeuro SA
INDUSTRY